Machine-Learning Tool Detects Cancer Earlier via Liquid Biopsy
Researchers developed a new machine-learning tool that could enable earlier cancer detection in patients via smaller blood draws
Read MorePosted by Andy Lundin | Jan 24, 2024 | Cancer |
Researchers developed a new machine-learning tool that could enable earlier cancer detection in patients via smaller blood draws
Read MorePosted by Andy Lundin | Jan 23, 2024 | Lung Cancer |
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Molecular Diagnostics |
The assay received a final Medicare coverage determination, providing access for Medicare and Medicare Advantage beneficiaries.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Lung Cancer |
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read MorePosted by Andy Lundin | Jan 9, 2024 | Cancer, Research |
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More